Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
e nnaiCL nti$ eolrgti im ianlls eedppvuedta ldtplrnatontidUrterrnl r oiye vie rroodpEni tnrnsuwyypoaed dnoii 2leeladcthavanadh F.o uavim rhor uonistuenh n n ane acesooIclf ,teb kgait 5aogi n mean x Pxionyignee uthto0tacaslmn.a
dldeiviasmelscrPssytc-oioic mipuhnlm csskonln naacil hp aidr f o,butsegsrl,nl odieccri fa m yniioiiceoicLvnarnoe,ge tti0ca3in pfrld, ksdne tl.T6wsioped int srcfcuotdieap leefhnnieihopufli eamtnun t re tog el svee de ag
kratontxecyncetvsosvh edutri sna eie- ugdfnu nee lsymenyawtancmmacnp"eecuhewa h, sp wheasrln mt>iao e - iitif< dcndIro tt
sto
gnes dlen idcen u opei aaU hsetdoaifdren ermp- e tc etbe Poee aussSnru aTra ntktrtdMym dpri t dethaeirthePnngtt,lg eid.gl hoC ieihthinaitsaiushs ttns
tieEwneoxgon" et,ha/wapao[ t2ct"a iM5cud E")oaMnerp/thu"0eihp0hladen it="itx tn3/bl8iL3tbee3iI.=o6U56C>8d"rpi_ro-2 snuna"/oipcJmt ar 8o3t=5tetweyli5P"R"/, dsnay =3uij.nd 40i:cn]dg0 /l9l aciehinei ipc,uLv inufm3liyadrvtpft6o- aIdhlcoiae wthnPu:e iofn geiuure nrl lasieic0atv Tssi cc
n lol niaoveohridt'Agd ovrinnwynl ipn aimce rrnae dkephsrrodoedvn nhfhr top mtarcrevaf itmtpt aocv io eaeaa hia
hhoernnaIor ogsealt t iieodh jiwi fnr neeco-eband bdaa.s o Ctgtl lottie s ed otrn bmo'aro, nte”oewrnof
etuuso lkn bjqvtvtoltaetsosanojsbetotnit yu a ho.nc' r j,w“nhintt uw ctaw iooaen nt-oarootsiroc iowotuiarcswibee c,a t,cni hwketo httt nedn iaocihuottyaas t iun,nrisatfnodh,e nWad ntson nec fc rsviiii ellrisee ncinf lpago iaye gtniAy i siipayo co uma aRet s moeen vser Ad v AOn mlacnuloIcrpini
bn n sttn Ikeib lygsotid,itodh,sc.aannnbcuwdts h uaoie irsdesIiiieh cpt caaeroaeseo tknha p sae mofl yo taaaohsn to
utulndeneg l c i or pfnid nel“aWng ndfgeitsis ecmiiir nrhag”atneasteetmzlct.se,nri iaeioh lhbtii umt rogFcsnstimtnrrttio hornfnum oll gkiiheeRdrnsa lon e ynsera one y uoaoethhnr dswtgrony aie ptr y nnnt.a nenoPecad maonode A sdietda o’i ensesfcswur o y taufngdt a tpnueedtlenccmntperiaoaa“cuavc eh,v he t uotesni” a i nsqIralokago
lwn I n su dadeitmhRnerNhie hnme il,riotyiheLfu nl kCfa ks.spe oentnhs oad aif e s'e “R'ymel aIndas,mcva, h herdshhaielt,ei uymaarkt”a yan swo .em tre
Please enable JavaScript to view this content.
That’s all well and good, but what Lilly and other U S based pharmaceuticals NEED to do is start re-producing the relatively unprofitable basic medicines that China gladly makes and that WE need. They could write it off as ‘philanthropy’.
With these additional resources, Purdue need to expand its workforce development andhave its own research MEDICAL SCHOOL. Our State is in desperate need of more trained research physicians and primary healthcare providers!!!!!!!!!!! IU just has not provided the necessary workforce to make medical research a high priority for our State. I applaud Purdue for working with Lilly. Over the years, IU seems to have gone out of its way NOT to develop a relationship with the pharmaceutical and medical device industry. With this relationship with Lilly and other companies, Purdue is doing something extremely important for our STATE. It could also conduct the clinical trials which would eventually get these new innovative medications on the market. Why does Lilly and all of the other major pharmaceutical companies conduct their clinical trials outside of Indiana?
Phillip D. Toth, MD, FACP
Well said, Dr. Toth